Categories: News

US Sets Off Major Global Shift of Top AI Talent

Zeki Data’s 2025 State of AI Talent Report Reveals 10 Market Shifting Predictions Based on the Top 800,000 Talent in AI

LONDON, April 30, 2025 /PRNewswire/ — Zeki Data, the UK-based data intelligence company, released the annual State of AI Talent Report 2025 today. The full report can be downloaded for free.

Zeki forecasts a dramatic shift in the flow of Top AI Talent around the world that will begin to address the imbalance of AI global innovation. The data is clear: US dominance in AI is fast eroding as the best minds in the field decide to take their skills elsewhere. In the short term, other countries will attract the Talent they have long regretted losing—the longer-term consequences for the US may be severe.

Attracting Top AI Talent is a zero-sum game—countries compete for a limited pool of individuals who have a proven, disproportionately positive impact on the innovation of the companies and nations they join. Zeki sees that opportunities abound for smaller companies to attract young emerging Talent as large companies employ AI in recruitment efforts that will result in a homogenised Talent pool.

The full report includes extensive data visualisations and Zeki’s 10 Top AI Talent predictions:

  1. The US will no longer be the destination of choice of Top AI Talent in 2025.
  2. India will become a consumer, not a provider, of Top AI Talent in 2025.
  3. Major AI players in Europe and the Gulf States will redouble efforts to retain their supply of Top AI Talent.
  4. Google’s talent concentration will set the stage of LLM dominance.
  5. London will be the new epicenter for responsible technology.
  6. Big Pharma will play it safe and outsource high-risk, high-reward AI Drug Discovery.
  7. Nvidia’s Talent magnetism will reinforce its innovation leadership.
  8. The intersection between quantum and AI will grow but to the detriment of pure quantum companies.
  9. AI companies will widen their search for Talent at a cost to medical research.
  10. The defence sector will buck the trend.

About Zeki Data

Zeki identifies and tracks the world’s Top AI Talent, individuals with proven track records of successfully testing the boundaries of AI science and engineering. We generate ‘frontier alpha signals’ that track and anticipate the innovation potential of individuals and the companies and countries they work in. Learn more at www.zekidata.com.

Photo – https://healthtechnologynet.com/wp-content/uploads/2025/04/Zeki_Data_Talent_Building_LLMs.jpg
Photo – https://healthtechnologynet.com/wp-content/uploads/2025/04/Zeki_Data_Net_Flows_Top_AI_Talent.jpg
Photo – https://healthtechnologynet.com/wp-content/uploads/2025/04/Zeki_Data_Defence_Visuals.jpg
Logo – https://mma.prnewswire.com/media/2463194/5295108/Zeki_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/us-sets-off-major-global-shift-of-top-ai-talent-302442717.html

SOURCE Zeki Data

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

23 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

23 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

23 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

23 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

23 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

23 hours ago